Your request to link to rcsb for PLpro/Z-RLRGG-AMC

• 1Q2W: x-ray crystal structure of the sars coronavirus main protease
• 1QZ8: crystal structure of sars coronavirus nsp9 (10.1073/PNAS.0307877101 )
• 1UJ1: crystal structure of sars coronavirus main proteinase (3clpro) (10.1073/PNAS.1835675100 )
• 1UK2: crystal structure of sars coronavirus main proteinase (3clpro) at ph8.0 (10.1073/PNAS.1835675100 )
• 1UK3: crystal structure of sars coronavirus main proteinase (3clpro) at ph7.6 (10.1073/PNAS.1835675100 )
• 1UK4: crystal structure of sars coronavirus main proteinase (3clpro) complexed with an inhibitor (10.1073/PNAS.1835675100 )
• 1UW7: nsp9 protein from sars-coronavirus. (10.1016/J.STR.2004.01.016 )
• 1WOF: crystal structure of sars-cov mpro in complex with an inhibitor n1 (10.1371/JOURNAL.PBIO.0030324 )
• 1YSY: nmr structure of the nonstructural protein 7 (nsp7) from the sars coronavirus (10.1128/JVI.79.20.12905-12913.2005 )
• 1Z1I: crystal structure of native sars clpro (10.1074/JBC.M502577200 )
• 1Z1J: crystal structure of sars 3clpro c145a mutant (10.1074/JBC.M502577200 )
• 2A5A: crystal structure of unbound sars coronavirus main peptidase in the space group c2 (10.1016/J.JMB.2005.09.004 )
• 2A5I: crystal structures of sars coronavirus main peptidase inhibited by an aza-peptide epoxide in the space group c2 (10.1016/J.JMB.2005.09.004 )
• 2A5K: crystal structures of sars coronavirus main peptidase inhibited by an aza-peptide epoxide in space group p212121 (10.1016/J.JMB.2005.09.004 )
• 2ACF: nmr structure of sars-cov non-structural protein nsp3a (sars1) from sars coronavirus (10.1016/J.STR.2005.07.022 )
• 2AHM: crystal structure of sars-cov super complex of non-structural proteins: the hexadecamer (10.1038/NSMB999 )
• 2ALV: x-ray structural analysis of sars coronavirus 3cl proteinase in complex with designed anti-viral inhibitors (10.1021/JM050548M )
• 2AMD: crystal structure of sars_cov mpro in complex with an inhibitor n9 (10.1371/JOURNAL.PBIO.0030324 )
• 2AMQ: crystal structure of sars_cov mpro in complex with an inhibitor n3 (10.1371/JOURNAL.PBIO.0030324 )
• 2BX3: crystal structure of sars coronavirus main proteinase (p43212) (10.1016/J.JMB.2005.09.012 )
• 2BX4: crystal structure of sars coronavirus main proteinase (p21212) (10.1016/J.JMB.2005.09.012 )
• 2C3S: structure of sars cov main proteinase at 1.9 a (ph6.5) (10.1107/S1744309105033257 )
• 2D2D: crystal structure of sars-cov mpro in complex with an inhibitor i2 (10.1371/JOURNAL.PBIO.0030324 )
• 2DUC: crystal structure of sars coronavirus main proteinase(3clpro) (10.1073/PNAS.1601327113 )
• 2FAV: crystal structure of sars macro domain in complex with adp- ribose at 1.8 a resolution (10.1128/JVI.00713-06 )
• 2FE8: sars coronavirus papain-like protease: structure of a viral deubiquitinating enzyme (10.1073/PNAS.0510851103 )
• 2FYG: crystal structure of nsp10 from sars coronavirus (10.1128/JVI.00467-06 )
• 2G9T: crystal structure of the sars coronavirus nsp10 at 2.1a (10.1128/JVI.00483-06 )
• 2GA6: the crystal structure of sars nsp10 without zinc ion as additive (10.1128/JVI.00483-06 )
• 2GDT: nmr structure of the nonstructural protein 1 (nsp1) from the sars coronavirus (10.1128/JVI.01939-06 )
• 2GRI: nmr structure of the sars-cov non-structural protein nsp3a (10.1128/JVI.00969-07 )
• 2GT7: crystal structure of sars coronavirus main peptidase at ph 6.0 in the space group p21 (10.1016/J.JMB.2006.11.078 )
• 2GT8: crystal structure of sars coronavirus main peptidase (with an additional ala at the n-terminus of each protomer) in the space group p43212 (10.1016/J.JMB.2006.11.078 )
• 2GTB: crystal structure of sars coronavirus main peptidase (with an additional ala at the n-terminus of each protomer) inhibited by an aza-peptide epoxide in the space group p43212 (10.1016/J.JMB.2006.11.078 )
• 2GX4: crystal structure of sars coronavirus 3cl protease inhibitor complex (10.1021/JM0603926 )
• 2GZ7: structure-based drug design and structural biology study of novel nonpeptide inhibitors of sars-cov main protease (10.1021/JM060207O )
• 2GZ8: structure-based drug design and structural biology study of novel nonpeptide inhibitors of sars-cov main protease (10.1021/JM060207O )
• 2GZ9: structure-based drug design and structural biology study of novel nonpeptide inhibitors of sars-cov main protease (10.1021/JM060207O )
• 2H2Z: crystal structure of sars-cov main protease with authentic n and c-termini (10.1016/J.JMB.2006.11.073 )
• 2HOB: crystal structure of sars-cov main protease with authentic n and c- termini in complex with a michael acceptor n3 (10.1016/J.JMB.2006.11.073 )
• 2HSX: nmr structure of the nonstructural protein 1 (nsp1) from the sars coronavirus (10.1128/JVI.01939-06 )
• 2IDY: nmr structure of the sars-cov non-structural protein nsp3a (10.1128/JVI.00969-07 )
• 2JZD: nmr structure of the domain 527-651 of the sars-cov nonstructural protein nsp3 (10.1128/JVI.01781-08 )
• 2JZE: nmr structure of the domain 527-651 of the sars-cov nonstructural protein nsp3, single conformer closest to the mean coordinates of an ensemble of twenty energy minimized conformers (10.1128/JVI.01781-08 )
• 2JZF: nmr conformer closest to the mean coordinates of the domain 513-651 of the sars-cov nonstructural protein nsp3 (10.1128/JVI.01781-08 )
• 2K7X: solution structure of c-terminal domain of sars-cov main protease (10.1002/PRO.76 )
• 2K87: nmr structure of a putative rna binding protein (sars1) from sars coronavirus (10.1128/JVI.01253-09 )
• 2KAF: solution structure of the sars-unique domain-c from the nonstructural protein 3 (nsp3) of the severe acute respiratory syndrome coronavirus (10.1016/J.JMB.2010.05.027 )
• 2KQV: sars coronavirus-unique domain (sud): three-domain molecular architecture in solution and rna binding. i: structure of the sud-m domain of sud-mc (10.1016/J.JMB.2010.05.027 )
• 2KQW: sars coronavirus-unique domain (sud): three-domain molecular architecture in solution and rna binding. ii: structure of the sud-c domain of sud-mc (10.1016/J.JMB.2010.05.027 )
• 2KYS: nmr structure of the sars coronavirus nonstructural protein nsp7 in solution at ph 6.5 (10.1016/J.JMB.2010.07.043 )
• 2LIZ: nmr solution structure of c-terminal domain of sars-cov main protease in 2.5m urea
• 2OP9: substrate specificity profiling and identification of a new class of inhibitor for the major protease of the sars coronavirus (10.1021/BI0621415 )
• 2PWX: crystal structure of g11a mutant of sars-cov 3c-like protease (10.1074/JBC.M705240200 )
• 2Q6G: crystal structure of sars-cov main protease h41a mutant in complex with an n-terminal substrate (10.1128/JVI.02114-07 )
• 2QC2: crystal structure of severe acute respiratory syndrome (sars) 3c-like protease asn214ala mutant
• 2QCY: crystal structure of a monomeric form of severe acute respiratory syndrome (sars) 3c-like protease mutant (10.1128/JVI.02680-07 )
• 2QIQ: structure-based design and synthesis and biological evaluation of peptidomimetic sars-3clpro inhibitors (10.1016/J.BMCL.2007.08.031 )
• 2RNK: nmr structure of the domain 513-651 of the sars-cov nonstructural protein nsp3 (10.1128/JVI.01781-08 )
• 2V6N: crystal structures of the sars-coronavirus main proteinase inactivated by benzotriazole compounds (10.1016/J.CHEMBIOL.2008.04.011 )
• 2VJ1: a structural view of the inactivation of the sars-coronavirus main proteinase by benzotriazole esters (10.1016/J.CHEMBIOL.2008.04.011 )
• 2W2G: human sars coronavirus unique domain (10.1371/JOURNAL.PPAT.1000428 )
• 2WCT: human sars coronavirus unique domain (triclinic form) (10.1371/JOURNAL.PPAT.1000428 )
• 2XYQ: crystal structure of the nsp16 nsp10 sars coronavirus complex (10.1371/JOURNAL.PPAT.1002059 )
• 2XYR: crystal structure of the nsp16 nsp10 sars coronavirus complex (10.1371/JOURNAL.PPAT.1002059 )
• 2XYV: crystal structure of the nsp16 nsp10 sars coronavirus complex (10.1371/JOURNAL.PPAT.1002059 )
• 2Z3C: a mechanistic view of enzyme inhibition and peptide hydrolysis in the active site of the sars-cov 3c-like peptidase (10.1016/J.JMB.2007.06.001 )
• 2Z3D: a mechanistic view of enzyme inhibition and peptide hydrolysis in the active site of the sars-cov 3c-like peptidase (10.1016/J.JMB.2007.06.001 )
• 2Z3E: a mechanistic view of enzyme inhibition and peptide hydrolysis in the active site of the sars-cov 3c-like peptidase (10.1016/J.JMB.2007.06.001 )
• 2Z94: complex structure of sars-cov 3c-like protease with tdt (10.1016/J.FEBSLET.2007.10.048 )
• 2Z9G: complex structure of sars-cov 3c-like protease with pma (10.1016/J.FEBSLET.2007.10.048 )
• 2Z9J: complex structure of sars-cov 3c-like protease with epdtc (10.1016/J.FEBSLET.2007.10.048 )
• 2Z9K: complex structure of sars-cov 3c-like protease with jmf1600 (10.1016/J.FEBSLET.2007.10.048 )
• 2Z9L: complex structure of sars-cov 3c-like protease with jmf1586 (10.1016/J.FEBSLET.2007.10.048 )
• 2ZU4: complex structure of sars-cov 3cl protease with tg-0204998 (10.1074/JBC.M807947200 )
• 2ZU5: complex structure of sars-cov 3cl protease with tg-0205486 (10.1074/JBC.M807947200 )
• 3ATW: structure-based design, synthesis, evaluation of peptide-mimetic sars 3cl protease inhibitors (10.1021/JM200870N )
• 3AVZ: structure of sars 3cl protease with peptidic aldehyde inhibitor containing cyclohexyl side chain (10.1021/JM200870N )
• 3AW0: structure of sars 3cl protease with peptidic aldehyde inhibitor (10.1021/JM200870N )
• 3AW1: structure of sars 3cl protease auto-proteolysis resistant mutant in the absent of inhibitor (10.1021/JM200870N )
• 3D62: development of broad-spectrum halomethyl ketone inhibitors against coronavirus main protease 3clpro (10.1111/J.1747-0285.2008.00679.X )
• 3E91: crystal structure of sars-cov mpro mutant in p21 at ph6.9
• 3E9S: a new class of papain-like protease/deubiquitinase inhibitors blocks sars virus replication
• 3EA7: crystal structure of sars-cov main protease triple mutant sti/a in space group p21
• 3EA8: crystal structure of sars-cov main protease triple mutant sti/a in space group c2
• 3EA9: crystal structure of sars-cov main protease quadruple mutant stif/a with one molecule in one asymmetric unit
• 3EAJ: crystal structure of sars-cov main protease quadruple mutant stif/a with two molecules in one asymmetric unit
• 3EBN: a special dimerization of sars-cov main protease c-terminal domain due to domain-swapping (10.1002/PRO.76 )
• 3EE7: crystal structure of sars-cov nsp9 g104e (10.1128/JVI.01505-08 )
• 3F9E: crystal structure of the s139a mutant of sars-coronovirus 3c-like protease (10.1016/J.VIROL.2009.03.034 )
• 3F9F: crystal structure of the f140a mutant of sars-coronovirus 3c-like protease at ph 6.0 (10.1016/J.VIROL.2009.03.034 )
• 3F9G: crystal structure of the f140a mutant of sars-coronovirus 3c-like protease at ph 6.5 (10.1016/J.VIROL.2009.03.034 )
• 3F9H: crystal structure of the f140a mutant of sars-coronovirus 3c-like protease at ph 7.6 (10.1016/J.VIROL.2009.03.034 )
• 3FZD: mutation of asn28 disrupts the enzymatic activity and dimerization of sars 3clpro (10.1021/BI1002585 )
• 3IWM: the octameric sars-cov main protease (10.1007/S13238-010-0044-8 )
• 3M3S: crystal structure of sars-cov main protease asn214ala mutant with authorize n-terminus
• 3M3T: sars-cov main protease monomeric arg298ala mutant with n-terminal additional residues (gly-ser)
• 3M3V: sars-cov main protease triple mutant sti/a with two n-terminal additional residue (gly-ser)
• 3MJ5: severe acute respiratory syndrome-coronavirus papain-like protease inhibitors: design, synthesis, protein-ligand x-ray structure and biological evaluation (10.1021/JM1004489 )
• 3R24: crystal structure of nsp10/nsp16 complex of sars coronavirus (10.1371/JOURNAL.PPAT.1002294 )
• 3SN8: crystal structure of sars coronavirus main protease complexed with cm- ff-h (soaking) 14-sep-11 3sn8 1 title (10.1016/J.ANTIVIRAL.2011.08.001 )
• 3SNA: crystal structure of sars coronavirus main protease complexed with ac- nsfsq-h (soaking) 14-sep-11 3sna 1 title (10.1016/J.ANTIVIRAL.2011.08.001 )
• 3SNB: crystal structure of sars coronavirus main protease complexed with ac- dsfdq-h (soaking) 14-sep-11 3snb 1 title (10.1016/J.ANTIVIRAL.2011.08.001 )
• 3SNC: crystal structure of sars coronavirus main protease complexed with ac- nstsq-h (soaking) 14-sep-11 3snc 1 title (10.1016/J.ANTIVIRAL.2011.08.001 )
• 3SND: crystal structure of sars coronavirus main protease complexed with ac- estlq-h (cocrystallization) 14-sep-11 3snd 1 title (10.1016/J.ANTIVIRAL.2011.08.001 )
• 3SNE: crystal structure of sars coronavirus main protease complexed with ac- estlq-h (soaking) 14-sep-11 3sne 1 title (10.1016/J.ANTIVIRAL.2011.08.001 )
• 3SZN: crystal structure of sars coronavirus main protease complexed with an alpha, beta-unsaturated ethyl ester sg75
• 3TIT: crystal structure of sars coronavirus main protease complexed with an alpha, beta-unsaturated ethyl ester sg81
• 3TIU: crystal structure of sars coronavirus main protease complexed with an alpha,beta-unsaturated ethyl ester inhibitor sg82
• 3TNS: crystal structure of sars coronavirus main protease complexed with an alpha, beta-unsaturated ethyl ester inhibitor sg83
• 3TNT: crystal structure of sars coronavirus main protease complexed with an alpha, beta-unsaturated ethyl ester inhibitor sg85
• 3V3M: severe acute respiratory syndrome coronavirus (sars-cov) 3cl protease in complex with n-[(1r)-2-(tert-butylamino)-2-oxo-1-(pyridin-3-yl) ethyl]-n-(4-tert-butylphenyl)furan-2-carboxamide inhibitor. (10.1021/JM301580N )
• 3VB3: crystal structure of sars-cov 3c-like protease in apo form (10.1016/J.EJMECH.2012.10.053 )
• 3VB4: crystal structure of sars-cov 3c-like protease with b4z (10.1016/J.EJMECH.2012.10.053 )
• 3VB5: crystal structure of sars-cov 3c-like protease with c4z (10.1016/J.EJMECH.2012.10.053 )
• 3VB6: crystal structure of sars-cov 3c-like protease with c6z (10.1016/J.EJMECH.2012.10.053 )
• 3VB7: crystal structure of sars-cov 3c-like protease with m4z (10.1016/J.EJMECH.2012.10.053 )
• 4HI3: crystal structure of dimeric r298a mutant of sars coronavirus main protease (10.1107/S0907444913001315 )
• 4M0W: crystal structure of sars-cov papain-like protease c112s mutant in complex with ubiquitin (10.1107/S1399004713031040 )
• 4MDS: discovery of n-(benzo[1,2,3]triazol-1-yl)-n-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (sars- cov) 3clpro inhibitors: identification of ml300 and non-covalent nanomolar inhibitors with an induced-fit binding (10.1016/J.BMCL.2013.08.112 )
• 4MM3: crystal structure of sars-cov papain-like protease plpro in complex with ubiquitin aldehyde (10.1371/JOURNAL.PPAT.1004113 )
• 4OVZ: x-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases (10.1021/JM401712T )
• 4OW0: x-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases (10.1021/JM401712T )
• 4TWW: structure of sars-3cl protease complex with a bromobenzoyl (s,r)-n- decalin type inhibitor (10.1016/J.BMC.2014.12.028 )
• 4TWY: structure of sars-3cl protease complex with a phenylbenzoyl (s,r)-n- decalin type inhibitor (10.1016/J.BMC.2014.12.028 )
• 4WY3: structure of sars-3cl protease complex with a phenylbenzoyl (r,s)-n- decalin type inhibitor (10.1016/J.BMC.2014.12.028 )
• 5B6O: crystal structure of ms8104 (10.1073/PNAS.1601327113 )
• 5C5N: structure of sars-3cl protease complex with a phenyl-beta-alanyl (r, s)-n-decalin type inhibitor
• 5C5O: structure of sars-3cl protease complex with a phenyl-beta-alanyl (s, r)-n-decalin type inhibitor
• 5C8S: crystal structure of the sars coronavirus nsp14-nsp10 complex with functional ligands sah and gpppa (10.1073/PNAS.1508686112 )
• 5C8T: crystal structure of the sars coronavirus nsp14-nsp10 complex with functional ligand sam (10.1073/PNAS.1508686112 )
• 5C8U: crystal structure of the sars coronavirus nsp14-nsp10 complex (10.1073/PNAS.1508686112 )
• 5E6J: structure of sars plpro bound to a lys48-linked di-ubiquitin activity based probe (10.1016/J.MOLCEL.2016.04.016 )
• 5F22: c-terminal domain of sars-cov nsp8 complex with nsp7
• 5N19: structure of sars coronavirus main protease in complex with the alpha- ketoamide (s)-n-benzyl-3-((s)-2-cinnamamido-3-phenylpropanamido)-2- oxo-4-((s)-2-oxopyrrolidin-3-yl)butanamide
• 5N5O: structure of sars coronavirus main protease in complex with the alpha- ketoamide (s)-n-benzyl-3-((s)-2-cinnamamido-3- cyclopropylpropanamido)-2-oxo-4-((s)-2-oxopyrrolidin-3-yl)butanamide (cinnamoyl-cyclopropylalanine-glnlactam-co-co-nh-benzyl)
• 5NFY: sars-cov nsp10/nsp14 dynamic complex (10.1073/PNAS.1718806115 )
• 5R7Y: pandda analysis group deposition -- crystal structure of covid-19 main protease in complex with z45617795 (10.1038/S41467-020-18709-W )
• 5R7Z: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z1220452176 (10.1038/S41467-020-18709-W )
• 5R80: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z18197050 (10.1038/S41467-020-18709-W )
• 5R81: pandda analysis group deposition -- crystal structure of covid-19 main protease in complex with z1367324110 (10.1038/S41467-020-18709-W )
• 5R82: pandda analysis group deposition -- crystal structure of covid-19 main protease in complex with z219104216 (10.1038/S41467-020-18709-W )
• 5R83: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z44592329 (10.1038/S41467-020-18709-W )
• 5R84: pandda analysis group deposition -- crystal structure of covid-19 main protease in complex with z31792168 (10.1038/S41467-020-18709-W )
• 5R8T: pandda analysis group deposition of ground-state model of sars-cov-2 main protease screened against dsi poised (enamine), fraglites and peplites (newcastle university), mini frags (astex), york 3d (york university), electrophile cysteine covalent (weizman institute) fragment libraries
• 5RE4: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z1129283193 (10.1038/S41467-020-18709-W )
• 5RE5: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z33545544 (10.1038/S41467-020-18709-W )
• 5RE6: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z54571979 (10.1038/S41467-020-18709-W )
• 5RE7: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z30932204 (10.1038/S41467-020-18709-W )
• 5RE8: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z2737076969 (10.1038/S41467-020-18709-W )
• 5RE9: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z2856434836 (10.1038/S41467-020-18709-W )
• 5REA: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z31432226 (10.1038/S41467-020-18709-W )
• 5REB: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z2856434899 (10.1038/S41467-020-18709-W )
• 5REC: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z1587220559 (10.1038/S41467-020-18709-W )
• 5RED: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z2856434865 (10.1038/S41467-020-18709-W )
• 5REE: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z2217052426 (10.1038/S41467-020-18709-W )
• 5REF: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z24758179 (10.1038/S41467-020-18709-W )
• 5REG: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z1545313172 (10.1038/S41467-020-18709-W )
• 5REH: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z111507846 (10.1038/S41467-020-18709-W )
• 5REI: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z2856434856 (10.1038/S41467-020-18709-W )
• 5REJ: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102241 (10.1038/S41467-020-18709-W )
• 5REK: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102327 (10.1038/S41467-020-18709-W )
• 5REL: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102340 (10.1038/S41467-020-18709-W )
• 5REM: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0103016 (10.1038/S41467-020-18709-W )
• 5REN: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102425 (10.1038/S41467-020-18709-W )
• 5REO: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102578 (10.1038/S41467-020-18709-W )
• 5REP: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102201 (10.1038/S41467-020-18709-W )
• 5RER: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102615 (10.1038/S41467-020-18709-W )
• 5RES: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102281 (10.1038/S41467-020-18709-W )
• 5RET: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102269 (10.1038/S41467-020-18709-W )
• 5REU: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102395 (10.1038/S41467-020-18709-W )
• 5REV: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0103072 (10.1038/S41467-020-18709-W )
• 5REW: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102275 (10.1038/S41467-020-18709-W )
• 5REX: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102287 (10.1038/S41467-020-18709-W )
• 5REY: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102911 (10.1038/S41467-020-18709-W )
• 5REZ: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pob0129 (10.1038/S41467-020-18709-W )
• 5RF0: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pob0073 (10.1038/S41467-020-18709-W )
• 5RF1: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with ncl-00023830 (10.1038/S41467-020-18709-W )
• 5RF2: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z1741969146 (10.1038/S41467-020-18709-W )
• 5RF3: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z1741970824 (10.1038/S41467-020-18709-W )
• 5RF4: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z1741982125 (10.1038/S41467-020-18709-W )
• 5RF5: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z3241250482 (10.1038/S41467-020-18709-W )
• 5RF6: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z1348371854 (10.1038/S41467-020-18709-W )
• 5RF7: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z316425948_minor (10.1038/S41467-020-18709-W )
• 5RF8: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z271004858 (10.1038/S41467-020-18709-W )
• 5RF9: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z217038356 (10.1038/S41467-020-18709-W )
• 5RFA: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z2643472210 (10.1038/S41467-020-18709-W )
• 5RFB: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z1271660837 (10.1038/S41467-020-18709-W )
• 5RFC: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z979145504 (10.1038/S41467-020-18709-W )
• 5RFD: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z126932614 (10.1038/S41467-020-18709-W )
• 5RFE: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with z509756472 (10.1038/S41467-020-18709-W )
• 5RFF: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102704 (10.1038/S41467-020-18709-W )
• 5RFG: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102372 (10.1038/S41467-020-18709-W )
• 5RFH: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102277 (10.1038/S41467-020-18709-W )
• 5RFI: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102353 (10.1038/S41467-020-18709-W )
• 5RFJ: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0103067 (10.1038/S41467-020-18709-W )
• 5RFK: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102575 (10.1038/S41467-020-18709-W )
• 5RFL: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102389 (10.1038/S41467-020-18709-W )
• 5RFM: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102539 (10.1038/S41467-020-18709-W )
• 5RFN: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102868 (10.1038/S41467-020-18709-W )
• 5RFO: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102972 (10.1038/S41467-020-18709-W )
• 5RFP: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102190 (10.1038/S41467-020-18709-W )
• 5RFQ: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102179 (10.1038/S41467-020-18709-W )
• 5RFR: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102169 (10.1038/S41467-020-18709-W )
• 5RFS: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102739 (10.1038/S41467-020-18709-W )
• 5RFT: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102432 (10.1038/S41467-020-18709-W )
• 5RFU: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102121 (10.1038/S41467-020-18709-W )
• 5RFV: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102306 (10.1038/S41467-020-18709-W )
• 5RFW: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102243 (10.1038/S41467-020-18709-W )
• 5RFX: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102254 (10.1038/S41467-020-18709-W )
• 5RFY: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102974 (10.1038/S41467-020-18709-W )
• 5RFZ: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102274 (10.1038/S41467-020-18709-W )
• 5RG0: pandda analysis group deposition -- crystal structure of sars-cov-2 main protease in complex with pcm-0102535 (10.1038/S41467-020-18709-W )
• 5RG1: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with ncl-00024905 (10.1038/S41467-020-18709-W )
• 5RG2: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with ncl-00025058 (10.1038/S41467-020-18709-W )
• 5RG3: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with ncl-00025412 (10.1038/S41467-020-18709-W )
• 5RGG: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z2856434890 (mpro-x0165) (10.1038/S41467-020-18709-W )
• 5RGH: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z1619978933 (mpro-x0395) (10.1038/S41467-020-18709-W )
• 5RGI: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z369936976 (mpro-x0397) (10.1038/S41467-020-18709-W )
• 5RGJ: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z1401276297 (mpro-x0425) (10.1038/S41467-020-18709-W )
• 5RGK: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z1310876699 (mpro-x0426) (10.1038/S41467-020-18709-W )
• 5RGL: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with pcm-0102962 (mpro-x0705) (10.1038/S41467-020-18709-W )
• 5RGM: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with pcm-0102142 (mpro-x0708) (10.1038/S41467-020-18709-W )
• 5RGN: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with pcm-0102759 (mpro-x0731) (10.1038/S41467-020-18709-W )
• 5RGO: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with pcm-0102248 (mpro-x0736) (10.1038/S41467-020-18709-W )
• 5RGP: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with pcm-0102628 (mpro-x0771) (10.1038/S41467-020-18709-W )
• 5RGQ: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z1849009686 (mpro-x1086) (10.1038/S41467-020-18709-W )
• 5RGR: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z328695024 (mpro-x1101) (10.1038/S41467-020-18709-W )
• 5RGS: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z1259086950 (mpro-x1163) (10.1038/S41467-020-18709-W )
• 5RGT: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z4439011607 (mpro-x2540)
• 5RGU: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z4444622180 (mpro-x2562)
• 5RGV: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z4444622066 (mpro-x2563)
• 5RGW: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z4444621910 (mpro-x2569)
• 5RGX: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z1344037997 (mpro-x2572)
• 5RGY: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z1535580916 (mpro-x2581)
• 5RGZ: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z1343543528 (mpro-x2600)
• 5RH0: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z1286870272 (mpro-x2608)
• 5RH1: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z2010253653 (mpro-x2643)
• 5RH2: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z1129289650 (mpro-x2646)
• 5RH3: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z1264525706 (mpro-x2649)
• 5RH4: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z1530425063 (mpro-x2659)
• 5RH5: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z4439011520 (mpro-x2694)
• 5RH6: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z4439011588 (mpro-x2703)
• 5RH7: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z4439011584 (mpro-x2705)
• 5RH8: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z4444621965 (mpro-x2764)
• 5RH9: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z4438424255 (mpro-x2776)
• 5RHA: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with z147647874 (mpro-x2779)
• 5RHB: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with cov_hetlib030 (mpro-x2097) (10.1038/S41467-020-18709-W )
• 5RHC: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with cov_hetlib053 (mpro-x2119) (10.1038/S41467-020-18709-W )
• 5RHD: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with sf013 (mpro-x2193) (10.1038/S41467-020-18709-W )
• 5RHE: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with pg-cov-42 (mpro-x2052) (10.1038/S41467-020-18709-W )
• 5RHF: pandda analysis group deposition sars-cov-2 main protease fragment screen -- crystal structure of sars-cov-2 main protease in complex with pg-cov-34 (mpro-x2754) (10.1038/S41467-020-18709-W )
• 5RL0: pandda analysis group deposition of computational designs of sars-cov- 2 main protease covalent inhibitors -- crystal structure of sars-cov- 2 main protease in complex with lon-wei-adc59df6-2 (mpro-x3110)
• 5RL1: pandda analysis group deposition of computational designs of sars-cov- 2 main protease covalent inhibitors -- crystal structure of sars-cov- 2 main protease in complex with lon-wei-adc59df6-27 (mpro-x3113)
• 5RL2: pandda analysis group deposition of computational designs of sars-cov- 2 main protease covalent inhibitors -- crystal structure of sars-cov- 2 main protease in complex with lon-wei-adc59df6-26 (mpro-x3115)
• 5RL3: pandda analysis group deposition of computational designs of sars-cov- 2 main protease covalent inhibitors -- crystal structure of sars-cov- 2 main protease in complex with lon-wei-adc59df6-39 (mpro-x3117)
• 5RL4: pandda analysis group deposition of computational designs of sars-cov- 2 main protease covalent inhibitors -- crystal structure of sars-cov- 2 main protease in complex with lon-wei-adc59df6-3 (mpro-x3124)
• 5RL5: pandda analysis group deposition of computational designs of sars-cov- 2 main protease covalent inhibitors -- crystal structure of sars-cov- 2 main protease in complex with lon-wei-adc59df6-30 (mpro-x3359)
• 5TL6: crystal structure of sars-cov papain-like protease in complex with the c-terminal domain of human isg15 (10.1016/J.JMB.2017.04.011 )
• 5TL7: crystal structure of sars-cov papain-like protease in complex with c- terminal domain mouse isg15 (10.1016/J.JMB.2017.04.011 )
• 5Y3E: crystal structure of sars coronavirus papain-like protease in complex with glycerol (10.1016/J.ANTIVIRAL.2017.12.015 )
• 5Y3Q: crystal structure of sars coronavirus papain-like protease conjugated with beta-mercaptoethanol (10.1016/J.ANTIVIRAL.2017.12.015 )
• 6LNQ: the co-crystal structure of sars-cov 3c like protease with aldehyde inhibitor m7 (10.1021/ACSCATAL.0C00110 )
• 6LNY: the co-crystal structure of severe acute respiratory syndrome coronavirus 3c-like protease with aldehyde m15 (10.1021/ACSCATAL.0C00110 )
• 6LO0: the co-crystal structure of severe acute respiratory syndrome coronavirus 3c like protease with aldehyde m14 (10.1021/ACSCATAL.0C00110 )
• 6LU7: the crystal structure of covid-19 main protease in complex with an inhibitor n3 (10.1038/S41586-020-2223-Y )
• 6LZE: the crystal structure of covid-19 main protease in complex with an inhibitor 11a (10.1126/SCIENCE.ABB4489 )
• 6M03: the crystal structure of covid-19 main protease in apo form
• 6M0K: the crystal structure of covid-19 main protease in complex with an inhibitor 11b (10.1126/SCIENCE.ABB4489 )
• 6M2N: sars-cov-2 3cl protease (3cl pro) in complex with a novel inhibitor (10.1038/S41401-020-0483-6 )
• 6M2Q: sars-cov-2 3cl protease (3cl pro) apo structure (space group c21) (10.1038/S41401-020-0483-6 )
• 6M5I: crystal structure of 2019-ncov nsp7-nsp8c complex
• 6M71: sars-cov-2 rna-dependent rna polymerase in complex with cofactors 08-apr-20 6m71 1 title (10.1126/SCIENCE.ABB7498 )
• 6NUR: sars-coronavirus nsp12 bound to nsp7 and nsp8 co-factors (10.1038/S41467-019-10280-3 )
• 6NUS: sars-coronavirus nsp12 bound to nsp8 co-factor (10.1038/S41467-019-10280-3 )
• 6W2A: 1.65 a resolution structure of sars-cov 3cl protease in complex with inhibitor 7j (10.1126/SCITRANSLMED.ABC5332 )
• 6W4B: the crystal structure of nsp9 rna binding protein of sars cov-2
• 6W4H: 1.80 angstrom resolution crystal structure of nsp16 - nsp10 complex from sars-cov-2 (10.1126/SCISIGNAL.ABE1202 )
• 6W61: crystal structure of the methyltransferase-stimulatory factor complex of nsp16 and nsp10 from sars cov-2.
• 6W63: structure of covid-19 main protease bound to potent broad-spectrum non-covalent inhibitor x77
• 6W75: 1.95 angstrom resolution crystal structure of nsp10 - nsp16 complex from sars-cov-2 (10.1126/SCISIGNAL.ABE1202 )
• 6W79: structure of sars-cov main protease bound to potent broad-spectrum non-covalent inhibitor x77
• 6W9Q: peptide-bound sars-cov-2 nsp9 rna-replicase (10.1016/J.ISCI.2020.101258 )
• 6WC1: peptide-bound sars-cov-2 nsp9 rna-replicase
• 6WCO: structure of sars main protease bound to inhibitor x47
• 6WIQ: crystal structure of the co-factor complex of nsp7 and the c-terminal domain of nsp8 from sars cov-2
• 6WJT: 2.0 angstrom resolution crystal structure of nsp16-nsp10 heterodimer from sars-cov-2 in complex with s-adenosyl-l-homocysteine (10.1126/SCISIGNAL.ABE1202 )
• 6WKQ: 1.98 angstrom resolution crystal structure of nsp16-nsp10 heterodimer from sars-cov-2 in complex with sinefungin (10.1126/SCISIGNAL.ABE1202 )
• 6WNP: x-ray structure of sars-cov-2 main protease bound to boceprevir at 1.45 a
• 6WQ3: crystal structure of nsp16-nsp10 heterodimer from sars-cov-2 in complex with 7-methyl-gpppa and s-adenosyl-l-homocysteine. (10.1126/SCISIGNAL.ABE1202 )
• 6WQD: the 1.95 a crystal structure of the co-factor complex of nsp7 and the c-terminal domain of nsp8 from sars-cov-2
• 6WQF: structural plasticity of the sars-cov-2 3cl mpro active site cavity revealed by room temperature x-ray crystallography (10.1038/S41467-020-16954-7 )
• 6WRZ: crystal structure of nsp16-nsp10 heterodimer from sars-cov-2 with 7- methyl-gpppa and s-adenosyl-l-homocysteine in the active site and sulfates in the mrna binding groove. (10.1126/SCISIGNAL.ABE1202 )
• 6WTC: crystal structure of the second form of the co-factor complex of nsp7 and the c-terminal domain of nsp8 from sars cov-2
• 6WTJ: feline coronavirus drug inhibits the main protease of sars-cov-2 and blocks virus replication (10.1038/S41467-020-18096-2 )
• 6WTK: feline coronavirus drug inhibits the main protease of sars-cov-2 and blocks virus replication (10.1038/S41467-020-18096-2 )
• 6WTM: feline coronavirus drug inhibits the main protease of sars-cov-2 and blocks virus replication (10.1038/S41467-020-18096-2 )
• 6WTT: crystals structure of the sars-cov-2 (covid-19) main protease with inhibitor gc-376 (10.1101/2020.04.20.051581 )
• 6WVN: crystal structure of nsp16-nsp10 from sars-cov-2 in complex with 7- methyl-gpppa and s-adenosylmethionine. (10.1126/SCISIGNAL.ABE1202 )
• 6WXD: sars-cov-2 nsp9 rna-replicase (10.1016/J.ISCI.2020.101258 )